When Death Is Present at Birth: Women's Experiences During Pregnancy (GADP)
When Death Is Present at Birth: Women's Experiences During Pregnancy Following Perinatal Bereavement, Psychological Adjustment, and Attachment Issues
Current scientific literature confirms that pregnancy following perinatal bereavement is a period of significant psychological vulnerability. Quantitative research highlights a high prevalence of anxiety disorders, depressive symptoms, and post-traumatic stress among these mothers. However, there is a significant gap between somatic medical monitoring-which has become highly effective-and an understanding of these women's subjective experiences. Data regarding the restructuring of prenatal attachment and "psychic transparency" in this context of traumatic aftermath remain extremely scarce. The purpose of this research is therefore to fill this gap by exploring, through a phenomenological approach, how the bond with the unborn child is formed when death occurred during the previous birth.
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
The originality of this research resides in its paradigm shift. It changes the focus from pathology (trauma as a disorder) to the phenomenology of the bond (the experience of attachment). While the majority of available studies on perinatal bereavement are quantitative in nature and focused on measuring psychological distress, this study offers a rare and deeply qualitative exploration of the "pregnancy that follows." Its innovative nature stems from the use of Interpretive Phenomenological Analysis (IPA), a methodology that has yet to be widely applied to this specific topic in France. This approach allows for a nuanced understanding of the psychological shifts and the uniqueness of "psychic transparency" among these women, where traditional measurement scales fail to capture the complexity of their lived experience.
Studietype
Registrering (Antatt)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
-
Pontoise, Frankrike, 95303
- Hôpital NOVO
-
Ta kontakt med:
- Aurelie BARIAN
- Telefonnummer: 01 30 75 57 76
- E-post: aurelie.barian@ght-novo.fr
-
Ta kontakt med:
- Emma DECHAUX
- Telefonnummer: 01 30 75 57 76
- E-post: emma.dechaux@psycho-prat.fr
-
Hovedetterforsker:
- Aurelie BARIAN
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Women aged 18 or older
- Medically confirmed ongoing pregnancy: at least 14 weeks of amenorrhea (SA), or at least 12 weeks of gestation,
- Receiving psychological counseling during the current pregnancy
- History of a perinatal loss as defined by the WHO (between 22 weeks of amenorrhea (SA) and the 7th day of life) during a previous pregnancy
- Ability to understand the information and sign an informed consent form
- Sufficient proficiency in French to participate in an interview
- Consent given for the audio recording of the interview
Exclusion Criteria:
- Serious obstetric complications in the current pregnancy (severe threat of preterm labor requiring hospitalization, preeclampsia, severe intrauterine growth restriction) or any maternal/fetal condition that is life-threatening in the short term.
- Severe or unstable psychiatric disorders (psychotic disorder) that may impair judgment or pose a risk of decompensation.
- A full-blown depressive episode or an ongoing suicidal crisis.
- A patient under guardianship, conservatorship, or judicial protection.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Annen
- Tildeling: N/A
- Intervensjonsmodell: Enkeltgruppeoppdrag
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Annen: Pregnant woman
Pregnant woman with a history of perinatal loss |
The semi-structured interview (single visit) is conducted immediately after enrollment, either before or after a scheduled visit as part of routine prenatal care. Lasting approximately 45 minutes, it is securely recorded. The "data collection" focuses exclusively on verbal data gathered during a semi-structured clinical interview. This data is collected via a digital audio recording, which is necessary for the accurate transcription of the speech for phenomenological analysis (IPA). |
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Nature and quality of the prenatal attachment
Tidsramme: 8 months
|
The primary assessment criteria collected during the semi-structured interview involve analyzing the nature and quality of the prenatal attachment bond (psychic investment). The purpose is to evaluate whether the attachment bond is formed with flexibility or is hindered by fear, by exploring the balance between the imaginary child and the fantasized child. |
8 months
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Experience of medical examinations
Tidsramme: 8 months
|
Response from the semi-structured interview |
8 months
|
|
Analysis of the place accorded to the deceased child
Tidsramme: 8 months
|
Response from the semi-structured interview |
8 months
|
|
Feelings toward the medical profession
Tidsramme: 8 months
|
Response from the semi-structured interview |
8 months
|
Samarbeidspartnere og etterforskere
Sponsor
Studierekorddatoer
Studer hoveddatoer
Studiestart (Antatt)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- 2026-A01510-51
- CHRD0726 (Annen identifikator: HOSPITAL NOVO)
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .